Introgen Therapeutics, Inc. (INGN) Announces Resignation of David G. Nance from Board of Directors
3/12/2009 9:21:26 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Common Stock to be Delisted from the Nasdaq Stock Market
12/8/2008 10:58:17 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Restructures Operations to Focus on Revenue-Generating Manufacturing Capabilities; Reduces Staff
12/1/2008 7:12:04 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Announces the Transfer of its Listing of Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market
11/19/2008 9:07:56 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Hires An Adviser To Pursue Strategic Options, Including A Possible Sale
11/12/2008 7:10:59 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Reports Third Quarter 2008 Financial Results
11/11/2008 9:45:39 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Receives Notification From NASDAQ
10/6/2008 10:49:46 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Receives Staff Determination Letter from Nasdaq Global Market
9/8/2008 9:13:06 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Sell-Off Continues
9/4/2008 11:25:03 AM
More...
|
Introgen Therapeutics, Inc. (INGN) Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
9/2/2008 6:37:25 AM
More...
|
|